Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

JDOC vs TRUH overlap: 62% of top holdings shared

Bottom line

How much do JDOC and TRUH overlap?

62% of their top holdings overlap by weight. 15 securities appear in both funds' top 25, making up 55.8% of JDOC's assets and 67.0% of TRUH's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

JDOCTRUH
Weight overlap (top 25)62%
Shared holdings15
Weight in shared holdings55.8%67.0%
Total positions6160
Expense ratio0.65%0.1%
Holdings as ofJul 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Holdings JDOC and TRUH have in common

Holding% of JDOC% of TRUHOverlap
AbbVie, Inc.7.85%7.76%7.76%
Eli Lilly & Co.7.76%16.56%7.76%
UnitedHealth Group, Inc.5.85%6.59%5.85%
Merck & Co., Inc.4.82%5.54%4.82%
Johnson & Johnson4.82%10.67%4.82%
Thermo Fisher Scientific, Inc.3.73%3.25%3.25%
Bristol-Myers Squibb Co.3.57%2.05%2.05%
Abbott Laboratories3.11%2.76%2.76%
CVS Health Corp.2.83%2.31%2.31%
Stryker Corp.2.23%1.89%1.89%
Danaher Corp.2.16%2.10%2.10%
Cencora, Inc.2.07%0.95%0.95%
Intuitive Surgical, Inc.1.93%2.48%1.93%
Regeneron Pharmaceuticals, Inc.1.60%1.12%1.12%
Cardinal Health, Inc.1.51%0.97%0.97%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in JDOC

  1. AstraZeneca plc — 3.76%
  2. Roche Holding AG — 2.82%
  3. Novo Nordisk A/S — 2.61%
  4. GSK plc — 2.47%
  5. Argenx SE — 2.06%
  6. Edwards Lifesciences Corp. — 1.73%
  7. IQVIA Holdings, Inc. — 1.71%
  8. Teva Pharmaceutical Industries Ltd. — 1.60%
  9. Novartis AG — 1.60%
  10. Biogen, Inc. — 1.56%

Only in TRUH

  1. Amgen Inc — 3.39%
  2. Gilead Sciences Inc — 2.74%
  3. Pfizer Inc — 2.40%
  4. Vertex Pharmaceuticals Inc — 2.21%
  5. Medtronic PLC — 1.76%
  6. McKesson Corp — 1.54%
  7. Elevance Health Inc — 1.49%
  8. Cigna Group/The — 1.26%
  9. Boston Scientific Corp — 1.11%
  10. HCA Healthcare Inc — 1.08%

Asset mix

Asset typeJDOCTRUH
Stocks99.2%99.9%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Country mix

CountryJDOCTRUH
US75.2%97.8%
GB6.2%—
CH4.4%—
DK4.0%—
JP2.5%—
NL2.4%—
IE0.4%2.1%
DE1.9%—

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do JDOC and TRUH overlap?
About 62% by weight. 15 securities appear in both funds' top 25 holdings; they make up 55.8% of JDOC's assets and 67.0% of TRUH's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do JDOC and TRUH have in common?
The largest shared holdings are AbbVie, Inc., Eli Lilly & Co., UnitedHealth Group, Inc., Merck & Co., Inc., Johnson & Johnson.
Should I own both JDOC and TRUH?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, JDOC or TRUH?
JDOC is broader, with 61 positions versus 60 for TRUH. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.